Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

MM-CEP/NLCs could effectively treat lung inflammation.

Lecithin-encapsulated resveratrol nanoparticles could be a safe and effective anti-cancer treatment.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

CTP-543 is generally safe for treating alopecia areata.

Bortezomib chemotherapy can cause temporary skin rashes.

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

A substance called sodium zinc dihydrolipoylhistidinate can significantly reduce hair loss caused by chemotherapy in rats.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Baricitinib was effective in treating both early and late onset alopecia areata.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Alpha mangostin may protect certain breast cancer cells by activating the p53 pathway.

Prostaglandins may protect hair follicles during chemotherapy.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Nanogels with hydrophobic modifications improve oral drug delivery for intestinal disease treatment.